<unk>  <unk>  is an autoimmune disorder stemming from an underlying tumor. It is hypothesized that antigens associated with the tumor trigger an immune response resulting in blistering of the skin and mucous membranes. While patients with malignant and benign tumors are both at risk, malignancy is associated with high mortality rates (near 90%). Current treatment focuses on general wound healing and administering corticosteroids, which has not demonstrated a high success rate. Recent research developments aim to treat the underlying tumor in order to alleviate the symptoms of<unk> .
Paraneoplastic pemphigus
IgA pemphigus
Poikiloderma vasculare atrophicans
Pemphigoid nodularis
Mucous membrane pemphigoid
Factitious dermatitis
Vesicular pemphigoid
Bullous pemphigoid